Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kees

Showing results (81-90 of 376) with videos related to

Pageof 38
Sort By:
European Journal of Preventive Cardiology|October 30, 2024
Impact of cumulative LDL cholesterol and other risk factors on coronary artery disease prevalence in patients with familial hypercholesterolaemiaShirin Ibrahim, G Kees Hovingh, Barbara A Hutten, et al.
International Journal of Molecular Sciences|December 17, 2024
Neutrophils in the Spotlight-An Analysis of Neutrophil Function and Phenotype in ARDSRichard F Kraus, Lisa Ott, Kirsten Utpatel, et al.
International Journal of Antimicrobial Agents|January 30, 2015
TDMx: a novel web-based open-access support tool for optimising antimicrobial dosing regimens in clinical routineSebastian G Wicha, Martin G Kees, Alexander Solms, et al.
Journal of Clinical Lipidology|February 24, 2020
ABCG5 and ABCG8 genetic variants in familial hypercholesterolemiaLaurens F Reeskamp, Andrea Volta, Linda Zuurbier, et al.
JAMA|March 11, 2015
Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitusJoost Besseling, John J P Kastelein, Joep C Defesche, et al.
Journal of the American Heart Association|June 14, 2024
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 InhibitionJordan M Kraaijenhof, Héléne T Cronjé, G Kees Hovingh, et al.
Journal of the American College of Cardiology|January 10, 2015
Reply: statin-induced low low-density lipoprotein cholesterol level: is lower better?S Matthijs Boekholdt, G Kees Hovingh, David D Waters, et al.
Atherosclerosis|February 18, 2014
Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriersJoost Besseling, Iris Kindt, Michel Hof, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 21, 2013
Evidence of a polygenic origin of extreme high-density lipoprotein cholesterol levelsMohammad Mahdi Motazacker, Jorge Peter, Marco Treskes, et al.
Blood|March 5, 2008
Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was basedMarcel Levi, G Kees Hovingh, Suzanne C Cannegieter, et al.
Pageof 38

Showing results (81-90 of 376) with videos related to

Sort By:
Pageof 38
European Journal of Preventive Cardiology|October 30, 2024
Impact of cumulative LDL cholesterol and other risk factors on coronary artery disease prevalence in patients with familial hypercholesterolaemiaShirin Ibrahim, G Kees Hovingh, Barbara A Hutten, et al.
International Journal of Molecular Sciences|December 17, 2024
Neutrophils in the Spotlight-An Analysis of Neutrophil Function and Phenotype in ARDSRichard F Kraus, Lisa Ott, Kirsten Utpatel, et al.
International Journal of Antimicrobial Agents|January 30, 2015
TDMx: a novel web-based open-access support tool for optimising antimicrobial dosing regimens in clinical routineSebastian G Wicha, Martin G Kees, Alexander Solms, et al.
Journal of Clinical Lipidology|February 24, 2020
ABCG5 and ABCG8 genetic variants in familial hypercholesterolemiaLaurens F Reeskamp, Andrea Volta, Linda Zuurbier, et al.
JAMA|March 11, 2015
Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitusJoost Besseling, John J P Kastelein, Joep C Defesche, et al.
Journal of the American Heart Association|June 14, 2024
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 InhibitionJordan M Kraaijenhof, Héléne T Cronjé, G Kees Hovingh, et al.
Journal of the American College of Cardiology|January 10, 2015
Reply: statin-induced low low-density lipoprotein cholesterol level: is lower better?S Matthijs Boekholdt, G Kees Hovingh, David D Waters, et al.
Atherosclerosis|February 18, 2014
Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriersJoost Besseling, Iris Kindt, Michel Hof, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 21, 2013
Evidence of a polygenic origin of extreme high-density lipoprotein cholesterol levelsMohammad Mahdi Motazacker, Jorge Peter, Marco Treskes, et al.
Blood|March 5, 2008
Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was basedMarcel Levi, G Kees Hovingh, Suzanne C Cannegieter, et al.
Pageof 38